Search

Your search keyword '"Cursi, Laura"' showing total 44 results

Search Constraints

Start Over You searched for: Author "Cursi, Laura" Remove constraint Author: "Cursi, Laura"
44 results on '"Cursi, Laura"'

Search Results

4. The Thousand Faces of Invasive Group A Streptococcal Infections: Update on Epidemiology, Symptoms, and Therapy

6. Monocyte‐to‐lymphocyte, neutrophil‐to‐lymphocyte and neutrophil‐to‐monocyte plus lymphocyte ratios in children with active tuberculosis: A multicentre study

8. Pediatric COVID-TB: A Clinical Perspective Based on the Analysis of Three Cases

9. The Prevalence of Carbapenemase-Producing Microorganisms and Use of Novel Cephalosporins for the Treatment of Severe Infections Caused by Carbapenem-Resistant Gram-Negative Bacteria in a Pediatric Cardiac Intensive Care Unit

12. Performance of QuantiFERON-TB Gold Plus assays in paediatric tuberculosis: a multicentre PTBNET study

13. One Year of Lung Ultrasound in Children with SARS-CoV-2 Admitted to a Tertiary Referral Children’s Hospital: A Retrospective Study during 2020–2021

14. Clostridioides difficile Infection in Children: A 5-Year Multicenter Retrospective Study

15. Performance of QuantiFERON-TB Gold Plus assays in paediatric tuberculosis: a multicentre PTBNET study.

16. Safety of Monoclonal Antibodies in Children Affected by SARS-CoV-2 Infection

17. Severe COVID-19 Complicated by Cerebral Venous Thrombosis in a Newborn Successfully Treated with Remdesivir, Glucocorticoids, and Hyperimmune Plasma

18. One year of Lung Ultrasound in children with SarsCoV2 infection admitted to a tertiary referral children’s hospital: a retrospective, single-center study, during 2020-2021 period.

20. VIROLOGICAL AND IMMUNOLOGICAL FEATURES OF SARS-COV-2 INFECTED CHILDREN WITH DISTINCT SYMPTOMATOLOGY

21. Virological and immunological features of SARS-CoV-2-infected children who develop neutralizing antibodies

25. Virological and immunological features of SARS‐COV‐2 infected children with distinct symptomatology.

26. Recommendations Concerning the First-Line Treatment of Children with Tuberculosis

27. MILD ENCEPHALOPATHY WITH A REVERSIBLE SPLENIAL LESION, A DIFFERENZIAL DIAGNOSIS TO CONSIDER IN CHILDREN

28. How to manage children who have come into contact with patients affected by tuberculosis

30. Acute cerebellitis in children: an eleven year retrospective multicentric study in Italy

31. 72nd Congress of the Italian Society of Pediatrics

32. NK cell effector functions in a Chédiak-Higashi patient undergoing cord blood transplantation: Effects of in vitro treatment with IL-2

34. Carbapenem-resistant Enterobacteriaceae Infections in Children

35. Pediatric Tuberculosis in Italian Children: Epidemiological and Clinical Data from the Italian Register of Pediatric Tuberculosis

37. Optimal Thalassemia Free Survival and Minimal Regimen Related Toxicity in 50 Consecutive Transplants of High Risk Beta Thalassemia Pediatric Patients Using Myelablative Therapy with Intravenous Busulphan.

39. 72nd Congress of the Italian Society of Pediatrics

40. Performance of QuantiFERON-TB Gold Plus assays in paediatric tuberculosis: a multicentre PTBNET study

41. Recommendations for treating children with drug-resistant tuberculosis

42. Carbapenem-resistant enterobacteriaceae infections in children: An Italian retrospective multicenter study

43. HHV6-related mild encephalopathy with reversible splenial lesion (MERS) presenting with urinary and fecal retention in an Italian adolescent.

44. Thymidine kinase and deoxycytidine kinase in HIV-infected children.

Catalog

Books, media, physical & digital resources